Unknown

Dataset Information

0

MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.


ABSTRACT: Neuroblastoma (NB) is the most common extracranial solid tumor in children. The outcomes for aggressive forms of NB remain poor. The aim of this study was to develop a new molecular-targeted therapy for NB using an antisense oligonucleotide (ASO) and superparamagnetic iron oxide (SPIO) nanoparticles (NPs), as a delivery vehicle, targeting the transcription regulator MAX dimerization protein 3 (MXD3). We previously discovered that MXD3 was highly expressed in high-risk NB, acting as an anti-apoptotic factor; therefore, it can be a good therapeutic target. In this study, we developed two ASO-NP complexes using electrostatic conjugation to polyethylenimine-coated SPIO NPs and chemical conjugation to amphiphilic polymers on amine-functionalized SPIO NPs. Both ASO-NP complexes demonstrated MXD3 knockdown, which resulted in apoptosis in NB cells. ASO chemically-conjugated NP complexes have the potential to be used in the clinic as they showed great efficacy with minimum NP-associated cytotoxicity.

SUBMITTER: Yoshida S 

PROVIDER: S-EPMC7515558 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5100699 | biostudies-literature
| S-EPMC4838932 | biostudies-literature
| S-EPMC6409598 | biostudies-literature
| S-EPMC5766481 | biostudies-literature
| S-EPMC9611043 | biostudies-literature
| S-EPMC5082301 | biostudies-literature
2015-10-12 | PXD000766 | Pride
| S-EPMC3834165 | biostudies-literature
| S-EPMC8636776 | biostudies-literature